Case Report: Fabry disease presenting with electrocardiographic findings mimicking acute myocardial infarction: a
Jin-Mei Xie1, Qing Li2,3,4, Zhi-Qiang Xiao1
1Departments of Electrocardiographic Diagnosis, Cardiovascular Medicine, and Ultrasound Medicine, Sanming First Affiliated Hospital to Fujian Medical University, Sanming, Fujian, China.
Insights
Fabry disease (FD) can mimic heart attacks with ECG changes and left ventricular hypertrophy. Early diagnosis through genetic testing and enzyme assays is crucial for timely treatment and management.
Area of Science:
- Cardiology
- Genetics
- Rare Diseases
Background:
- Fabry disease (FD) is a rare X-linked lysosomal storage disorder causing cardiac complications.
- Cardiac involvement includes left ventricular hypertrophy and arrhythmias due to glycosphingolipid accumulation.
- Some FD patients present with electrocardiographic findings mimicking acute myocardial infarction (AMI).
Abstract:
Fabry disease (FD) is a rare X-linked lysosomal storage disorder characterized by heterogeneous clinical manifestations. Cardiac involvement arises from progressive glycosphingolipid accumulation within cardiomyocytes, vascular endothelium, and the conduction system, resulting in left ventricular hypertrophy, conduction abnormalities, and arrhythmias. A subset of patients exhibits electrocardiographic findings that mimic acute myocardial infarction (AMI), often leading to misdiagnosis as ischemic heart disease.
Case Presentation:
We describe a 62-year-old man presenting with recurrent chest pain and syncope. Initial electrocardiography demonstrated pathological Q waves and ST-segment elevation in the anterior leads. Echocardiography revealed concentric left ventricular hypertrophy. Serial cardiac biomarkers, repeat echocardiography, and coronary angiography excluded AMI. The diagnosis of FD was confirmed by markedly reduced leukocyte α-galactosidase A activity, elevated plasma lyso-Gb3 concentrations, and identification of a pathogenic hemizygous variant in the GLA gene.
Conclusion:
In patients with unexplained left ventricular hypertrophy and "pseudo-infarction" electrocardiographic patterns, targeted evaluation for FD is warranted to prevent diagnostic delay and enable timely initiation of enzyme replacement therapy (ERT) and multidisciplinary management.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
